Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1158/1078-0432.CCR-20-2224

http://scihub22266oqcxt.onion/10.1158/1078-0432.CCR-20-2224
suck pdf from google scholar
32616498!ä!32616498

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32616498      Clin+Cancer+Res 2020 ; 26 (18): 4737-4742
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID-19 Testing in Patients with Cancer: Does One Size Fit All? #MMPMID32616498
  • Madariaga A; McMullen M; Sheikh S; Kumar R; Liu FF; Zimmermann C; Husain S; Zadeh G; Oza AM
  • Clin Cancer Res 2020[Sep]; 26 (18): 4737-4742 PMID32616498show ga
  • The COVID-19 global pandemic has drastically impacted cancer care, posing challenges in treatment and diagnosis. There is increasing evidence that cancer patients, particularly those who have advanced age, significant comorbidities, metastatic disease, and/or are receiving active immunosuppressive therapy may be at higher risk of COVID-19 severe complications. Controlling viral spread from asymptomatic carriers in cancer centers is paramount, and appropriate screening methods need to be established. Universal testing of asymptomatic cancer patients may be key to ensure safe continuation of treatment and appropriate hospitalized patients cohorting during the pandemic. Here we perform a comprehensive review of the available evidence regarding SARS-CoV-2 testing in asymptomatic cancer patients, and describe the approach adopted at Princess Margaret Cancer Centre (Toronto, Canada) as a core component of COVID-19 control.
  • |*Point-of-Care Testing[MESH]
  • |Asymptomatic Diseases/epidemiology[MESH]
  • |Betacoronavirus/genetics[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Testing[MESH]
  • |Clinical Laboratory Techniques/*methods[MESH]
  • |Coronavirus Infections/*diagnosis/prevention & control[MESH]
  • |Early Diagnosis[MESH]
  • |Humans[MESH]
  • |Neoplasms/pathology[MESH]
  • |Pandemics/prevention & control[MESH]
  • |Pneumonia, Viral/*diagnosis/prevention & control[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box